| dc.creator |
Demir, Nazlim A. |
|
| dc.creator |
Sumer, Sua |
|
| dc.creator |
Celik, Gulperi |
|
| dc.creator |
Afsar, Rengin |
|
| dc.creator |
Ural, Onur |
|
| dc.creator |
Demir, Lutfi S. |
|
| dc.date |
2018-09-30T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T09:50:12Z |
|
| dc.date.available |
2020-10-06T09:50:12Z |
|
| dc.identifier |
4d809ce9-e156-4391-ad64-e8e784309ebc |
|
| dc.identifier |
10.1111/imj.13952 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/4d809ce9-e156-4391-ad64-e8e784309ebc/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/59646 |
|
| dc.description |
Background: Procalcitonin (PCT) and C-reactive protein (CRP) are used most widely in the diagnosis/treatment of bacterial infections. These are not infection-specific and may also show increases in other inflammation-causing cases. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients? |
|
| dc.type |
info:eu-repo/semantics/article |
|